These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol. Cheng EY, Luthy DA, Zebelman AM, Williams MA, Lieppman RE, Hickok DE. Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967 [Abstract] [Full Text] [Related]
4. Triploidy identified through second-trimester serum screening. Huang T, Alberman E, Wald N, Summers AM. Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661 [Abstract] [Full Text] [Related]
13. 46,XY,i(21q) identified by maternal serum screening. Meyers CM, Ghori S, Roberson AE, Blitzer MG, Cohen MM. Md Med J; 1997 Feb; 46(2):88-9. PubMed ID: 9029908 [Abstract] [Full Text] [Related]
14. Are Down syndrome fetuses detected through maternal serum screening similar to those remaining undetected? Christiaens GC, Hagenaars AM, Akkerman C, De France HF. Prenat Diagn; 1996 May; 16(5):437-42. PubMed ID: 8844002 [Abstract] [Full Text] [Related]
19. Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction. Groutz A, Amit A, Yaron Y, Yovel I, Wolman I, Legum C, Lessing JB. Prenat Diagn; 1996 Aug; 16(8):723-7. PubMed ID: 8878282 [Abstract] [Full Text] [Related]